South Korea · Delayed Price · Currency is KRW IntoCell Statistics
Total Valuation
IntoCell has a market cap or net worth of KRW 572.37 billion. The enterprise value is 549.15 billion.
| Market Cap | 572.37B |
| Enterprise Value | 549.15B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
IntoCell has 14.85 million shares outstanding. The number of shares has increased by 3.28% in one year.
| Current Share Class | 14.85M |
| Shares Outstanding | 14.85M |
| Shares Change (YoY) | +3.28% |
| Shares Change (QoQ) | +5.18% |
| Owned by Insiders (%) | 22.63% |
| Owned by Institutions (%) | 9.56% |
| Float | 11.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 459.35 |
| PB Ratio | 22.75 |
| P/TBV Ratio | 27.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -46.16 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -63.03 |
Financial Position
The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.40.
| Current Ratio | 5.81 |
| Quick Ratio | 5.80 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.16 |
| Interest Coverage | -41.98 |
Financial Efficiency
Return on equity (ROE) is -71.40% and return on invested capital (ROIC) is -27.05%.
| Return on Equity (ROE) | -71.40% |
| Return on Assets (ROA) | -21.37% |
| Return on Invested Capital (ROIC) | -27.05% |
| Return on Capital Employed (ROCE) | -30.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 28,627.00 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 70.42 |
| Average Volume (20 Days) | 526,573 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IntoCell had revenue of KRW 1.25 billion and -11.90 billion in losses. Loss per share was -886.52.
| Revenue | 1.25B |
| Gross Profit | 1.24B |
| Operating Income | -11.58B |
| Pretax Income | -11.90B |
| Net Income | -11.90B |
| EBITDA | -10.90B |
| EBIT | -11.58B |
| Loss Per Share | -886.52 |
Balance Sheet
The company has 33.32 billion in cash and 10.09 billion in debt, giving a net cash position of 23.23 billion or 1,564.50 per share.
| Cash & Cash Equivalents | 33.32B |
| Total Debt | 10.09B |
| Net Cash | 23.23B |
| Net Cash Per Share | 1,564.50 |
| Equity (Book Value) | 25.16B |
| Book Value Per Share | 1,694.64 |
| Working Capital | 28.91B |
Cash Flow
In the last 12 months, operating cash flow was -8.63 billion and capital expenditures -78.86 million, giving a free cash flow of -8.71 billion.
| Operating Cash Flow | -8.63B |
| Capital Expenditures | -78.86M |
| Free Cash Flow | -8.71B |
| FCF Per Share | -586.77 |
Margins
| Gross Margin | 99.58% |
| Operating Margin | -928.93% |
| Pretax Margin | -954.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IntoCell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.28% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.08% |
| FCF Yield | -1.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IntoCell has an Altman Z-Score of 15.55 and a Piotroski F-Score of 3.
| Altman Z-Score | 15.55 |
| Piotroski F-Score | 3 |